Brief: Aravive Initiates A Phase 2A Clinical Trial Of AVB-500 In Patients With Kidney Fibrosis
20/12/2019 13:09
Dec 20 (Reuters) - Aravive Inc ARAV.O :
* ARAVIVE INITIATES A PHASE 2A CLINICAL TRIAL OF AVB-500 IN
PATIENTS WITH KIDNEY FIBROSIS
Source text for Eikon: ID:nGNXH8yXm
Further company coverage: ARAV.O
((Reuters.Briefs@thomsonreuters.com;))